Skip to main content
Premium Trial:

Request an Annual Quote

Tranzyme, Active Pass Enter Gene Expression Collaboration

NEW YORK, Sept. 20 – Tranzyme of Birmingham, Ala., and Active Pass Pharmaceuticals of Vancouver, said Thursday they had agreed to combine their technologies in an effort to study gene expression and bolster their drug discovery programs.

Under the terms of the deal, Active Pass will provide sets of gene sequences that make up the molecular pumps, or ABC transporters, located in the membranes of all cells, while Tranzyme will use its Tranz Expression Technology to deliver these genes into mammalian cells. By doing this, the companies said they would be able to gain a better of understanding of tene expression and the proteins involved in cells of interest.

"Combining Tranzyme's technology with our existing suite of ABC transporter gene sequences is a key step in advancing our chemogenomic strategy," Peter Reiner, CEO of Active Pass Pharmaceuticals, said in a statement.

Financial terms of the deal were not disclosed.

Tranzyme said its deal with Active Pass was its second since introducing the Tranz Expression Technology in August. Last month, the company announced a collaboration with NeoGenesis Drug Discovery of Cambridge, Mass. Tranzyme said it is in talks with at least 12 potential partners.

Tranzyme is a privately held biotechnology company that develops technologies for applied genomics, proteomics, and drug discovery.

Active Pass Pharmaceuticals is also privately held. Its main objective is to develop drugs that target ABC transporters.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.